GoozNews

Home
Archive
Leaderboard
About
Obesity: Disease or surrogate marker?
People get sick and die from the diseases triggered by obesity, not from obesity itself. Studying outcomes from the use of GLP-1s should also be on the…
 • 
Merrill Goozner
Ending the Medicare Advantage advantage
The outgoing Biden team just proposed MA plans receive an unwarranted 4.3% bump in payments next year. It could get a lot worse with the surgeon turned…
 • 
Merrill Goozner
A plan to make drugs affordable for all
Insurance should protect against misfortune, not place additional burdens on the sick. Here's a better way to pay for drugs, protect patients, and…
 • 
Merrill Goozner
The inadequate Medicaid-to-ACA shift
The outgoing Biden administration recorded the highest ever enrollment in Affordable Care Act plans in 2025 amid rapidly falling Medicaid enrollment.
 • 
Merrill Goozner
3
The state of the union’s health
Despite a post-Covid jump in life expectancy in 2023, the U.S. remains far behind other advanced industrial nations.
 • 
Merrill Goozner
4

December 2024

Thank you and happy holidays
I am pleased to report readership grew 27% this year. Here's are the top ten most read stories.
 • 
Merrill Goozner
3
The 'skin in the game' gambit has failed
Here's a program to limit out-of-pocket costs and insurer overreach: Put a cap on household spending and put providers on a budget.
 • 
Merrill Goozner
4
A plan to end unaffordable out-of-pocket costs
Put a cap on it that is based on household income. It's doable if we put providers on a budget.
 • 
Merrill Goozner
7
Trump's latest inheritance
This morning, President Joe Biden makes the case that his successor will inherit a strong, growing economy whose Covid-driven inflationary woes are…
 • 
Merrill Goozner
One other good idea from RFK Jr.: Boost primary care
While public health advocates are mobilizing to thwart the anti-vaxxer's confirmation, his acolytes want to revamp physician pay to boost primary care…
 • 
Merrill Goozner
4
Paul Krugman, pragmatic Keynesian, leaving the Times
When writing about health care, the Nobel Prize-winning economist wanted single-payer but defended Obamacare.
 • 
Merrill Goozner
3
The contrarian addiction
Dr. Marty Makary, Trump's nominee to head the Food and Drug Administration, hunts for evidence in studies that should never pass muster at the agency he…
 • 
Merrill Goozner
3
© 2025 Merrill Goozner
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture